Divalproex Sodium Tablet, Extended Release
Product Images NDC 0904-7182

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 0904-7182). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton Label (Ef472176 7f98 4f88 Be5e A101fecb46fd 00)

This is a description of a drug product called "Divalproex Sodium Extended-Release Tablets". It comes in a container of 100 unit dose tablets. The product is only available via a prescription. The text provides detailed instructions on how to take the product and caution statements. The drug should be stored in a controlled storage temperature of 20 -25°C. It also contains directions for pharmacists to dispense the product in a light-resistant container to ensure quality.*

FDA Label Image

Carton Label (Ef472176 7f98 4f88 Be5e A101fecb46fd 01)

The text is a product description for a medication called Divalproex Sodium, with an NDC code of 09047181, manufactured by Major Pharmaceuticals. The medication is in the form of extended-release tablets, to be taken once a day and contains USP controlled room temperature. The text includes instructions for usage and storage of the medication, as well as a warning to keep it away from children. There is also mention of an insert or guide available on Major Pharmaceuticals' website for more information.*

FDA Label Image

10 (Divalproex Sodium Extended Release Tablets Usp 1)

FDA Label Image

Figure 1 (Divalproex Sodium Extended Release Tablets Usp 2)

FDA Label Image

Figure 2 (Divalproex Sodium Extended Release Tablets Usp 3)

The text contains a graph that shows the percentage reduction in CPS rate and how it correlates to high and low dose Divalproex Sodium. The X-axis shows the percentage of patients, while the Y-axis represents the level of improvement or worsening of the condition. The graph depicts that High Dose Divalproex Sodium has a higher efficacy than Low Dose Divalproex Sodium.*

FDA Label Image

Figure 3 (Divalproex Sodium Extended Release Tablets Usp 4)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.